HCV Triple Threat
By: Marcus Hopkins, Blogger
Here, at HEAL Blog, weve talked often about the cost of Gilead
Sciences Sovaldi as a treatment regimen for patient either mono- or
co-infected with the Hepatitis C Virus (HCV). Thanks in no small part to
the introductory pricing of this and other HCV therapies, the discussion
of pharmaceutical pricing is in the news, again, in a way that it hasnt
really been in nearly a decade.
CLICK HERE to read, "HCV Triple Threat"
Black Market HIV/AIDS Drugs in the News, 2006 -
The Partnership for Safe Medicines
The Community Access National Network (CANN) today announced that it is teaming
up with the Partnership for Safe Medicines (PSM) to better educate patients
about the risks of counterfeit or black market HIV/AIDS medicines. Since
2006, eighty-two (82) individuals have been charged with selling adulterated,
unapproved or black market medications prescribed for HIV or AIDS patients.
HERE to download, "Black Market HIV/AIDS Drugs in the News, 2006 - 2013"